Cucurbitacin IIb exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes.
Cucurbitacin IIb (CuIIb) is one of the major active compounds in Hemsleyadine tablets which have been used for clinical treatment of bacillary dysentery, enteritis and acute tonsilitis. However, its action mechanism has not been completely understood. This study aimed to explore the anti-inflammator...
Principais autores: | Yao Wang, Gao-Xiang Zhao, Li-Hui Xu, Kun-Peng Liu, Hao Pan, Jian He, Ji-Ye Cai, Dong-Yun Ouyang, Xian-Hui He |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Public Library of Science (PLoS)
2014-01-01
|
coleção: | PLoS ONE |
Acesso em linha: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089751&type=printable |
Registros relacionados
-
Cucurbitacin IIb alleviates colitis via regulating gut microbial composition and metabolites
por: Yinyin Zhao, et al.
Publicado em: (2024-09-01) -
Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential
por: Sreekumar Usha Devi Aiswarya, et al.
Publicado em: (2022-06-01) -
VASP activation via the Gα13/RhoA/PKA pathway mediates cucurbitacin-B-induced actin aggregation and cofilin-actin rod formation.
por: Yan-Ting Zhang, et al.
Publicado em: (2014-01-01) -
Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential
por: Sreekumar Usha Devi Aiswarya, et al.
Publicado em: (2022-08-01) -
Anti-Diabetic Effects of Cucurbitacins from Ibervillea lindheimeri on Induced Mouse Diabetes
por: Sonia E. Hernández Navia, et al.
Publicado em: (2022-01-01)